Sat.Apr 06, 2024 - Fri.Apr 12, 2024

article thumbnail

Opinion: H5N1 bird flu in U.S. cattle: A wake-up call to action

STAT

The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a dairy worker contracting the virus , demands a departure from the usual reassurances offered by federal health officials. While they emphasize there’s no cause for alarm and assert diligent monitoring, it’s imperative we break from this familiar script. H5N1, a strain of the flu virus known to infect bird species globally and several mammalian species in the U.S. since 2022, has now appeared to have bre

364
364
article thumbnail

Next-gen menopause treatments have blockbuster potential. Can women, doctors and payers be convinced?

PharmaVoice

The market is huge, but will companies overcome the triple hurdles of payer hesitance, prescriber reluctance and sluggish consumer demand?

306
306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pigtail catheter for pleural drainage: Tips to minimize complications

ALiEM - Pharm Pearls

Traditionally large-bore tube thoracostomy has been the standard of care for treating many acute intrathoracic pathologies [1]. However, the advent of less invasive small-bore chest tubes, also known as pigtail catheters, has gradually led to a paradigm shift. Pigtails provide a less invasive and often better tolerated alternative to traditional chest tubes and allow for adequate treatment of pneumothoraces and uncomplicated pleural effusions [1-5].

Inpatient 183
article thumbnail

Study suggests tumour microenvironments could predict cancer progression

Pharma Times

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases

158
158
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

$10 billion long Covid ‘moonshot’ is being floated by Bernie Sanders 

STAT

WASHINGTON — Bernie Sanders is pushing for a long Covid “moonshot.” He released a draft legislative proposal this week, a follow up to a milestone hearing in January that sounded the alarm on long Covid as a pressing public health crisis. The pitch calls for $10 billion in mandatory funding over the next decade to establish a new long Covid research program at the National Institutes of Health.

363
363
article thumbnail

What’s old is new: The revival of a one-time radiotherapy cancer treatment

PharmaVoice

TAE Life Sciences is bringing radiation-based cancer therapy to clinical trials globally in the coming years.

298
298

More Trending

article thumbnail

Researchers call to reduce repeat antibiotic prescriptions for respiratory tract infections

Pharma Times

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR

151
151
article thumbnail

STAT+: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

STAT

Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the program billions of dollars by next year — well beyond what Wall Street or even the drug’s manufacturer have projected — according to a document obtained by STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medica

article thumbnail

Unlocking growth: How GenAI can help pharma companies convert new clients

PharmaVoice

GenAI is profoundly reshaping various facets of the pharmaceutical industry. Projections indicate that the global GenAI market in pharma will soar to USD 2258.1 million by 2032.

264
264
article thumbnail

Calls to pharmacies tripled during pandemic, inquiry told

The Pharmacist

The number of phone calls to pharmacies more than tripled between February and March 2020, while home deliveries of medication to vulnerable patients more than doubled, the UK Covid-19 Inquiry heard this week. Speaking on behalf of the National Pharmacy Association (NPA) at the inquiry hearing this week, legal representative Deirdre Domingo, said members had […] The post Calls to pharmacies tripled during pandemic, inquiry told appeared first on The Pharmacist.

133
133
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Unitaid funds over £6m to Liverpool researchers to treat major diseases

Pharma Times

The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs

142
142
article thumbnail

STAT+: Cancer vaccines gain momentum, after years of disappointing results

STAT

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. But as researchers from different companies and academic institutions presented promising early data at the American Association for Cancer Research annual meeting in San Diego this week, experts said there’s a collective feeling of turning a corner. “There’s a lot more interest in vaccines” now that the technology is improving, said Roy Herbst, chief of medical oncology at Yale Can

Vaccines 363
article thumbnail

Women want to participate in clinical trials. Lack of flexibility is still a problem.

PharmaVoice

Underrepresentation of women in clinical trials affects the resulting drugs that are available down the line. Encouraging more women to partake is a critical step in promoting more equitable healthcare.

264
264
article thumbnail

Pharmacy First: Top tips for managing non-bullous impetigo

The Pharmacist

Most community pharmacies in England now running the Pharmacy First service which enables them to diagnose and treat seven specific conditions. Under the service, pharmacists can prescribe set medications where appropriate, without recourse to a GP. This will hopefully reduce some of the current pressures on general practice. This series of guides assumes that pharmacists […] The post Pharmacy First: Top tips for managing non-bullous impetigo appeared first on The Pharmacist.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Alliance Healthcare launches cancer symptom referral scheme in UK pharmacies

Pharma Times

Around three million people in the UK were estimated to be living with cancer in 2022

136
136
article thumbnail

STAT+: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers

STAT

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.  MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer.

Diabetes 363
article thumbnail

3 big recent trial flops

PharmaVoice

Why these clinical setbacks impacted the companies, industry and patients.

246
246
article thumbnail

UK calls time-out on post-Brexit rules opposed by industry

pharmaphorum

The UK has agreed to delay border checks on products used in life sciences R&D and manufacturing, says industry group BIA.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancer

Pharma Times

Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies

135
135
article thumbnail

Opinion: The time has come for over-the-counter antidepressants

STAT

Anyone can now walk into a pharmacy in the United States and buy oral contraceptives over the counter without a prescription, thanks to the FDA’s approval of norgestrel (Opill). This change reflects the drug’s safety and the public health imperative to ensure wider access to birth control. But another safe class of medicine that addresses a massive public health need remains unavailable except by prescription: the antidepressants known as selective serotonin reuptake inhibitor

364
364
article thumbnail

Psychiatry drugs finally have pharma’s attention. Can they keep it?

PharmaVoice

Recent biotech company acquisitions have put emerging schizophrenia treatments in focus. But many development hurdles still stand in the way of new medicines for the brain.

240
240
article thumbnail

New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.

BioPharma Dive

The first medicine approved for PPD, Sage’s Zulresso, never gained traction. The company is in the midst of launching its second, but long-standing challenges could slow uptake.

130
130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

US researchers reveal positive results of personalised vaccine for liver cancer

Pharma Times

Hepatocellular carcinoma is one of the leading causes of cancer-related deaths worldwide

Vaccines 132
article thumbnail

STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way

STAT

It seemed as if Logan Jenner had the best possible chance for a cure. Diagnosed at age 3 with acute myeloid leukemia, an aggressive blood cancer, Logan happened to have a targetable mutation that occurs in a small minority of childhood AML cases, making it possible for him to receive a precision therapy drug that — with chemotherapy — got him to a point where he could receive a bone marrow transplant.

article thumbnail

Pharma’s drumbeat to justify drug prices is at odds with consumer sentiments

PharmaVoice

More than 20% of Americans are forgoing prescription medications due to costs, but the industry continues to fight policy measures.

article thumbnail

Measles cases in London now in line with West Midlands

The Pharmacist

A rise in measles cases in London has brought the capital in line with the number of cases recorded in the West Midlands – the initial hotspot for the virus. This comes as the rise in cases appears to be plateauing across the country and as a national catch-up campaign has increased vaccination uptake over […] The post Measles cases in London now in line with West Midlands appeared first on The Pharmacist.

Vaccines 130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Vertex to buy kidney disease drugmaker Alpine for $4.9B

BioPharma Dive

The deal, which company CEO Reshma Kewalramani described as “just the right fit,” is the largest acquistion in Vertex’s 35-year history.

126
126
article thumbnail

STAT+: New liquid biopsy screening test for pancreatic cancer shows promise in early data

STAT

For the vast majority of pancreatic cancer cases, the tumor grows undetected until it has already spread locally or to distant parts of the body. That means most patients, over 80% by some estimates, are diagnosed when it’s already too late to do surgery — depriving them of their best chance for a cure. “For the majority of patients, we cannot resect the tumor.

363
363
article thumbnail

Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future

PharmaVoice

Biosimilars promise market competition for branded biologics, which in theory could drive down prices. But so far, winning market share has been a struggle.

article thumbnail

PCPA joins calls for healthcare protection in conflict areas

The Pharmacist

The Primary Care Pharmacy Association (PCPA) has joined other healthcare organisations in calling for the safeguarding of healthcare facilities and personnel in areas of conflict. Dr Graham Stretch, PCPA president, told The Pharmacist that he signed the open letter, coordinated by the World Health Professions Alliance, last week following a short discussion with the PCPA executive committee. […] The post PCPA joins calls for healthcare protection in conflict areas appeared first on The Pha

128
128
article thumbnail

Culmination Bio and BillionToOne partner to advance cancer diagnosis

Pharma Times

Both will validate the clinical performance of two new diagnostic tests for regulatory submission

125
125